seed
Stage
2
Investors
About
FerryX develops next-generation probiotics designed to support gut health, particularly for individuals with chronic conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Unlike conventional probiotics, FerryX products can function during active inflammation and stress, providing relief when conventional options fail.
Explore FerryX Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.